We propose to evaluate, prospectively, the impact of moderate daily alcohol consumption, regular weekly patterns of consumption, and usual percent of alcohol consumed with meals, on risk of diabetes mellitus, hypertension, cardiovascular disease and total mortality in large cohort studies of 51,529 middle-aged men who were 40 to 75 years of age at baseline in 1986 (Health Professionals Follow-up Study), and 116,601 young women who were 25 to 42 years of age at baseline in 1989 (Nurses' Health Study II). In addition, using samples (n=500 men and 500 women) of stored plasma from 18,018 men who provided blood specimens in 1993-94 and from an anticipated 40,000 women who will provede blood samples in 1995-96, we propose to evaluate the impact of moderate alcohol consumption on plasma lipids and thrombotic factors related to risk of coronary heart disease. Using a cross-sectional design we propose to evaluate the relationship between alcohol consumption patterns and levels of plasma HDL-cholesterol, tissue-type plasminogen activator (t-PA), fibrinogen, factor VII activity, and von Willebrand Factor independent of obesity, physical activity, and dietary intake of saturated fac, cholesterol, and total energy. Finally, in a nested case-control study of CHD, we propose to evaluate simultaneously the relationship between alcohol consumption patterns, biomarkers, and risk of coronary heart disease to quantitate the importanceof each biomarker in explaining the reported inverse association between alcohol consumption and risk of coronary heart disease. The ongoing HPFS (CA55075 HL35464) and NHS II (CA50385) will provide follow-up and documentation of hypertension, cardiovascular disease, and mortality in addition tocovariate information. Overall, the large size of these cohorts, the prospective design, the high follow-up rates, the detailed alcohol data, and the availability of archived blood specimens provide a unique opportunity to test a number of hypotheses of public health importance, using a highly cost-effective design.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA011181-03
Application #
2894152
Study Section
Special Emphasis Panel (ZRG2-SSP (01))
Program Officer
Chiapella, Page
Project Start
1997-09-01
Project End
2002-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Harvard University
Department
Nutrition
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Del Gobbo, Liana C; Imamura, Fumiaki; Aslibekyan, Stella et al. (2016) ?-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. JAMA Intern Med 176:1155-66
Holmes, Michael V; Dale, Caroline E; Zuccolo, Luisa et al. (2014) Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 349:g4164
Li, Shanshan; Flint, Alan; Pai, Jennifer K et al. (2014) Dietary fiber intake and mortality among survivors of myocardial infarction: prospective cohort study. BMJ 348:g2659
Li, Shanshan; Flint, Alan; Pai, Jennifer K et al. (2014) Low carbohydrate diet from plant or animal sources and mortality among myocardial infarction survivors. J Am Heart Assoc 3:e001169
Li, Shanshan; Chiuve, Stephanie E; Flint, Alan et al. (2013) Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med 173:1808-18
Pai, Jennifer K; Mukamal, Kenneth J; Rimm, Eric B (2012) Long-term alcohol consumption in relation to all-cause and cardiovascular mortality among survivors of myocardial infarction: the Health Professionals Follow-up Study. Eur Heart J 33:1598-605
de Koning, Lawrence; Malik, Vasanti S; Kellogg, Mark D et al. (2012) Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation 125:1735-41, S1
de Koning, Lawrence; Liptak, Cary; Shkreta, Aida et al. (2012) A multiplex immunoassay gives different results than singleplex immunoassays which may bias epidemiologic associations. Clin Biochem 45:848-51
Jensen, Majken K; Rimm, Eric B; Furtado, Jeremy D et al. (2012) Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease. J Am Heart Assoc 1:
Chomistek, Andrea K; Chiuve, Stephanie E; Jensen, Majken K et al. (2011) Vigorous physical activity, mediating biomarkers, and risk of myocardial infarction. Med Sci Sports Exerc 43:1884-90

Showing the most recent 10 out of 62 publications